Literature DB >> 332636

Canine migration inhibitory factor: effect of Corynebacterium parvum administration.

M S Pineiro, C A Bowles, E C Cutchins, M I Bull.   

Abstract

Peripheral blood lymphocytes from dogs sensitized to streptolysin O (SLO) were assayed for migration inhibitory factor (MIF) production by the indirect MIF test, using guinea pig peritoneal exudate cells as the source of macrophages. A specific direct correlation was established between the degree of inhibition of migration and the concentration of SLO-stimulated supernatants from lymphocyte cultures (SLO-S) of untreated normal dogs. Undiluted SLO-S inhibited migration by 66.8%, whereas a dilution of 1:64 elicited a 3% inhibition. In parallel tests, purified protein derivative stimulation of lymphocytes from BCG-vaccinated dogs produced 92.6% inhibition. The effect of Corynebacterium parvum on SLO-specific MIF production was evaluated in three groups of dogs administered a single intramuscular injection of C. parvum at 5 or 50 mg/m(2) or 50 mg/m(2) in suspension with 10 mg of methylprednisolone. Inhibition of migration of macrophages exposed to a 1:4 dilution of SLO-S from dogs inoculated with C. parvum (5 mg/m(2)) was 33% greater (mean inhibition, 75%) than the same SLO-S dilution from uninoculated normal dogs (mean inhibition, 42%) (P < 0.0002). Similarly, lymphocytes from dogs administered 50 mg/m(2) caused an enhancement of migration inhibition, with a mean increase of 26% over controls (P < 0.002), whereas a dose of 50 mg/m(2) with methylprednisolone produced a 16% increase in migration inhibition (P < 0.05). The administration of C. parvum resulted in a three- to fourfold increase in the SLO-S dilution, which would reduce migration by 20% (MIF titer). This increase peaked between days 20 and 30 and lasted over 50 days post-C. parvum inoculation. These findings indicate that C. parvum specifically increases MIF production by canine lymphocytes in a linear correlation with SLO concentration and suggest its use as a stimulant of canine immunity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 332636      PMCID: PMC421200          DOI: 10.1128/iai.18.1.102-109.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation.

Authors:  R H Kelly; R A Wolstencroft; D C Dumonde; B M Balfour
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

2.  Partial characterization of murine migration inhibitory factor (MIF).

Authors:  A L Kühner; J R David
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

3.  Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer.

Authors:  C G Moertel; R E Ritts; A J Schutt; R G Hahn
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

4.  Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.

Authors:  M T Scott
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

5.  The growth of tumours in T-cell deprived mice and their response to treatment with Corynebacterium parvum.

Authors:  M Woodruff; N Dunbar; A Ghaffar
Journal:  Proc R Soc Lond B Biol Sci       Date:  1973-08-31

6.  Inhibition of macrophage migration by normal guinea pig intestinal secretions.

Authors:  N Gadol; R H Waldman; L W Clem
Journal:  Proc Soc Exp Biol Med       Date:  1976-04

7.  Mchanisms of antitumor action of Corynebacterium parvum: nonspecific tumor cell destruction at site of immunologically mediated sensitivity reaction to C. parvum.

Authors:  R L Tuttle; R J North
Journal:  J Natl Cancer Inst       Date:  1975-12       Impact factor: 13.506

8.  Tumor immunity: tumor suppression in vivo initiated by soluble products of specifically stimulated lymphocytes.

Authors:  I D Bernstein; D E Thor; B Zbar; H J Rapp
Journal:  Science       Date:  1971-05-14       Impact factor: 47.728

9.  Antitumour effect of corynebacterium parvum. Possible mode of action.

Authors:  M Baum; M Breese
Journal:  Br J Cancer       Date:  1976-04       Impact factor: 7.640

10.  Thymus-derived lymphocytes produce an immunologically specific macrophage-arming factor.

Authors:  R Evans; C K Grant; H Cox; K Steele; P Alexander
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.